[Study of rapidity of hypotensive effects of acebutolol on non hospitalized patients (author's transl)].
Acebutolol whose hypotensive properties are well established, appears as a most interesting beta-adrenergic blocking agent for simplification of treatment of moderate hypertension in man. Hypertensive patients likely to benefit from treatment with acebutolol can be identified within 5 days after administration of a single initial dose of the product. Long-term treatment with acebutolol can be considered in those patients identified as receptive. In non-responders, acebutolol can be used in combination with a diuretic agent. Such simplification of the therapeutic schedule in hypertension will certainly be helpfull both to the physician and his patient.
D000070:Acebutolol / Q000008:administration & dosage* / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000553:Ambulatory Care; D002986:Clinical Trials as Topic; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008134:Long-Term Care; D008875:Middle Aged; D010919:Placebos; D013997:Time Factors
D010919:Placebos; D000070:Acebutolol
Mesure de la rapidité de l'action hypotensive de l'acébutolol sur des patients ambulatoires.